Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRY INSIGHTS
5.1 NEW PRODUCT LAUNCHES:
5.2 REGULATIONS FOR IMMUNOASSAY REAGENT AND DEVICE MARKET –
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING INCIDENCE OF CHRONIC AND INFECTIOUS DISEASES IN NORTH AMERICA
6.1.2 EMERGENCE OF COVID-19 PANDEMIC IN NORTH AMERICA
6.1.3 WIDE APPLICATION OF IMMUNOASSAY IN NORTH AMERICA
6.1.4 INCREASING HEALTHCARE EXPENDITURE IN NORTH AMERICA
6.1.5 WIDE USE IN DRUG SCREENING TESTS IN NORTH AMERICA
6.2 RESTRAINTS
6.2.1 HIGH COST OF IMMUNOASSAY KITS AND DEVICES IN NORTH AMERICA
6.2.2 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES IN NORTH AMERICA
6.3 OPPORTUNITIES
6.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES
6.3.2 STRATEGIC INITATIVES BY THE COMPANIES
6.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY
6.4 CHALLENGES
6.4.1 AVAILABILITY OFALTERNATIVE TECHNOLOGIES
6.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY
7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 REAGENTS & KITS
7.2.1 ELISA REAGENTS & KITS
7.2.1.1 THIRD-GENERATION ELISA
7.2.1.2 FIFTH-GENERATION ELISA
7.2.1.3 FOURTH-GENERATION ELISA
7.2.1.4 FIRST-GENERATION ELISA
7.2.1.5 SECOND-GENERATION ELISA
7.2.2 ELISPOT REAGENTS & KITS
7.2.3 RAPID TEST REAGENTS & KITS
7.2.4 WESTERN BLOT REAGENTS & KITS
7.2.5 OTHER REAGENTS & KITS
7.3 ANALYZERS
7.3.1 BY TYPE
7.3.1.1 OPEN-ENDED SYSTEMS
7.3.1.2 CLOSED-ENDED SYSTEMS
7.3.2 BY DEVICE TYPE
7.3.2.1 BENCH-TOP
7.3.2.2 FLOOR STANDING
8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM
8.1 OVERVIEW
8.2 ENZYME IMMUNOASSAY
8.3 FLUORESCENCE IMMUNOASSAYS
8.4 CHEMILUMINESCENCE IMMUNOASSAYS
8.5 RADIOIMMUNOASSAYS
8.6 OTHERS
9 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE
9.1 OVERVIEW
9.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS
9.3 ENZYME-LINKED IMMUNOSPOT
9.4 RAPID TESTS
9.5 WESTERN BLOTTING
9.6 IMMUNO-PCR
9.7 OTHER TECHNIQUES
10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE
10.1 OVERVIEW
10.2 BLOOD
10.3 URINE
10.4 SALIVA
10.5 OTHERS
11 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ONCOLOGY AND ENDOCRINOLOGY
11.3 HEMATOLOGY & BLOOD SCREENING
11.4 CARDIOLOGY
11.5 INFECTIOUS DISEASES
11.6 BONE & MINERAL DISORDERS
11.7 AUTOIMMUNE DISORDERS
11.8 TOXICOLOGY
11.9 NEONATAL SCREENING
11.1 OTHER APPLICATIONS
12 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER
12.1 OVERVIEW
12.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.3 CLINICAL LABORATORIES
12.4 HOSPITALS
12.5 RESEARCH & ACADEMIC LABORATORIES
12.6 BLOOD BANKS
12.7 OTHERS
13 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY REGION
13.1 NORTH AMERICA MARKET
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 COMPANY PROFILE
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 ABBOTT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 2.3 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 DIASORIN S.P.A
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 PERKINELMER INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 BIOMÉRIEUX SA
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 BD
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 BECKMAN COULTER, INC (A SUBSIDIARY OF DANAHER)
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIOCHECK, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BIO-TECHNE
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENTS
15.11 BIO-RAD LABORATORIES, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENTS
15.12 LUMINEX CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 MERCK KGAA
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 MESO SCALE DIAGNOSTICS, LLC
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 ORTHO CLINICAL DIAGNOSTICS
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 QIAGEN
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 QUIDEL CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENTS
15.18 RANDOX LABORATORIES LTD.
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 SIEMENS
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
15.21 SYSMEX CORPORATION
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 THERMO FISHER SCIENTIFIC INC.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 COST OF ELISA KITS BY CELL SCIENCES, INC.
TABLE 2 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 23 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 24 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 25 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 26 U.S. REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 27 U.S. ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 28 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 29 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 30 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 31 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 32 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 33 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 34 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 35 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 36 CANADA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 37 CANADA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 39 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 40 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 41 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 42 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 43 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 44 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 45 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 46 MEXICO REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 MEXICO ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 49 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 50 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 51 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 52 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DROC ANALYSIS
FIGURE 4 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NOTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 REAGENTS & KITS SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET
FIGURE 14 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT, 2020
FIGURE 15 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, 2020
FIGURE 16 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TECHNIQUE, 2020
FIGURE 17 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, 2020
FIGURE 18 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, 2020
FIGURE 19 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, 2020
FIGURE 20 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2020)
FIGURE 21 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020)
FIGURE 22 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 23 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 24 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2021 & 2028)
FIGURE 25 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2020 (%)
